Ljiljana Trtica Majnaric (Ljiljana Majnarić Trtica, Ljiljana Trtica Majnarić, Ljiljana Trtica Majnarić, Mario Štefanić)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 19

Top Topics

Oxidative Stress

Helicobacter Pylori Infection

Top Venues

International journal of environmental research and public health

Journal of clinical medicine

Healthcare (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Mile Volarić, Dunja Šojat, Ljiljana Trtica Majnaric, Domagoj Vučić
The Association between Functional Dyspepsia and Metabolic Syndrome-The State of the Art. International journal of environmental research and public health 21 (2) (2024)
Mile Volarić, Dunja Šojat, Ljiljana Trtica Majnaric, Domagoj Vučić
The Association between Functional Dyspepsia and Metabolic Syndrome-The State of the Art. International journal of environmental research and public health 21 (2) (2024)
Tomislav Kurevija, Dunja Šojat, Zvonimir Bosnic, Blerim Mujaj, Silvija Canecki Varžić, Ljiljana Trtica Majnaric
The Reasons for the Low Uptake of New Antidiabetic Drugs with Cardiovascular Effects-A Family Doctor Perspective. Journal of clinical medicine 13 (6) (2024)
Mile Volarić, Dunja Šojat, Ljiljana Trtica Majnaric, Domagoj Vučić
The Association between Functional Dyspepsia and Metabolic Syndrome-The State of the Art. International journal of environmental research and public health 21 (2) (2024)
Dunja Šojat, Mile Volarić, Tanja Keškić, Nikola Volarić, Venija Cerovečki, Ljiljana Trtica Majnaric
Putting Functional Gastrointestinal Disorders within the Spectrum of Inflammatory Disorders Can Improve Classification and Diagnostics of These Disorders. Biomedicines 12 (3) (2024)
Tomislav Kurevija, Dunja Šojat, Zvonimir Bosnic, Blerim Mujaj, Silvija Canecki Varžić, Ljiljana Trtica Majnaric
The Reasons for the Low Uptake of New Antidiabetic Drugs with Cardiovascular Effects-A Family Doctor Perspective. Journal of clinical medicine 13 (6) (2024)
Dunja Šojat, Mile Volarić, Tanja Keškić, Nikola Volarić, Venija Cerovečki, Ljiljana Trtica Majnaric
Putting Functional Gastrointestinal Disorders within the Spectrum of Inflammatory Disorders Can Improve Classification and Diagnostics of These Disorders. Biomedicines 12 (3) (2024)
Zvonimir Bosnic, František Babič, Viera Anderková, Ljiljana Trtica Majnaric, Thomas Wittlinger, Ljiljana Trtica Majnarić
A Critical Appraisal of the Diagnostic and Prognostic Utility of the Anti-Inflammatory Marker IL-37 in a Clinical Setting: A Case Study of Patients with Diabetes Type 2. International journal of environmental research and public health 20 (4) (2023)
Zvonimir Bosnic, František Babič, Viera Anderková, Ljiljana Trtica Majnaric, Thomas Wittlinger, Ljiljana Trtica Majnarić
A Critical Appraisal of the Diagnostic and Prognostic Utility of the Anti-Inflammatory Marker IL-37 in a Clinical Setting: A Case Study of Patients with Diabetes Type 2. International journal of environmental research and public health 20 (4) (2023)
Ema Schönberger, Vjera Mihaljević, Kristina Steiner, Sandra Šarić, Tomislav Kurevija, Ljiljana Trtica Majnaric, Ines Bilić Ćurčić, Silvija Canecki-Varžić
Immunomodulatory Effects of SGLT2 Inhibitors-Targeting Inflammation and Oxidative Stress in Aging. International journal of environmental research and public health 20 (17) (2023)
Zvonimir Bosnic, František Babič, Viera Anderková, Ljiljana Trtica Majnaric, Thomas Wittlinger, Ljiljana Trtica Majnarić
A Critical Appraisal of the Diagnostic and Prognostic Utility of the Anti-Inflammatory Marker IL-37 in a Clinical Setting: A Case Study of Patients with Diabetes Type 2. International journal of environmental research and public health 20 (4) (2023)
Zvonimir Bosnic, František Babič, Viera Anderková, Ljiljana Trtica Majnaric, Thomas Wittlinger, Ljiljana Trtica Majnarić
A Critical Appraisal of the Diagnostic and Prognostic Utility of the Anti-Inflammatory Marker IL-37 in a Clinical Setting: A Case Study of Patients with Diabetes Type 2. International journal of environmental research and public health 20 (4) (2023)
Zvonimir Bosnic, František Babič, Viera Anderková, Ljiljana Trtica Majnaric, Thomas Wittlinger, Ljiljana Trtica Majnarić
A Critical Appraisal of the Diagnostic and Prognostic Utility of the Anti-Inflammatory Marker IL-37 in a Clinical Setting: A Case Study of Patients with Diabetes Type 2. International journal of environmental research and public health 20 (4) (2023)
Ljiljana Trtica Majnaric, Zvonimir Bosnic, Mario Štefanić, Thomas Wittlinger
Cross-Talk between the Cytokine IL-37 and Thyroid Hormones in Modulating Chronic Inflammation Associated with Target Organ Damage in Age-Related Metabolic and Vascular Conditions. International journal of molecular sciences 23 (12) (2022)
Ljiljana Trtica Majnaric, František Babič, Shane O'Sullivan, Andreas Philipp Hassler
AI and Big Data in Healthcare: Towards a More Comprehensive Research Framework for Multimorbidity. Journal of clinical medicine 10 (4) (2021)
Ljiljana Trtica Majnaric, Zvonimir Bosnic, Silva Guljaš, Domagoj Vučić, Tomislav Kurevija, Mile Volarić, Ivo Martinović, Thomas Wittlinger
Low Psychological Resilience in Older Individuals: An Association with Increased Inflammation, Oxidative Stress and the Presence of Chronic Medical Conditions. International journal of molecular sciences 22 (16) (2021)
Sanja Bekić, František Babič, Viera Pavlišková, Ján Paralič, Thomas Wittlinger, Ljiljana Trtica Majnaric
Clusters of Physical Frailty and Cognitive Impairment and Their Associated Comorbidities in Older Primary Care Patients. Healthcare (Basel, Switzerland) 9 (7) (2021)
Zvonimir Bosnic, Pinar Yildirim, František Babič, Ines Šahinović, Thomas Wittlinger, Ivo Martinović, Ljiljana Trtica Majnaric
Clustering Inflammatory Markers with Sociodemographic and Clinical Characteristics of Patients with Diabetes Type 2 Can Support Family Physicians' Clinical Reasoning by Reducing Patients' Complexity. Healthcare (Basel, Switzerland) 9 (12) (2021)
Ljiljana Trtica Majnaric, Silva Guljaš, Zvonimir Bosnic, Vatroslav Šerić, Thomas Wittlinger
Neutrophil-to-Lymphocyte Ratio as a Cardiovascular Risk Marker May Be Less Efficient in Women Than in Men. Biomolecules 11 (4) (2021)